Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMRA Colostrum for Gut Health and Exercise Performance
NCT05831527Completed
- Sponsor
- ARMRA
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by ARMRA. Primary endpoints: Change in overall well-being at 12 weeks and Change in hs-CRP at 12 weeks. Started Sep 2022; status: completed.
Beyond the preview
Go deeper on NCT05831527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05831527.